Introduction
Optic neuritis (ON) is an inflammation of the optic nerve (1) . One of the most common complications of vaccination against viral pathogens and viral infections is acute ON (2) (3) (4) (5) . Typical characteristics in young adults are sudden monocular loss of vision accompanied by eye pain and it occurs more frequently in women than in men. ON is often observed in patients with multiple sclerosis (MS) (6, 7) and experimental autoimmune encephalomyelitis (EAE) in various animal species, including the mouse (5, (8) (9) (10) (11) , rat (12) , guinea pig (13) , and primates (14, 15) . Development of ON after induction of EAE suggests an autoimmune origin of the optic nerve inflammation observed in MS. Previous studies have demonstrated that MS is an autoimmune disease of the central nervous system (CNS) that appears to be mediated in part by T cells (16) . Some studies have shown that regulatory T cells (Treg) play a critical role in the progression of the disease (17) . T helper cells (Th) are also believed to contribute to pathogenesis, but the specific cell types involved are not well understood. Most studies usually focus on the injury of the brain and spinal cord, rather than the optic nerve. In the present study, we investigated optic neuritis induced by encephalitogenic peptides derived from myelin oligodendrocyte glycoprotein (MOG), to establish a working model for ON, in nontransgenic mice on a B6 genetic background and to further determine the role of T helper cell subsets such as Th1, Th2, Th17 and Treg in the pathogenesis of optic neuritis in EAE.
Materials and methods
Materials. MOG peptide was synthesized and purified at CL (Xian) Bio-Scientific Co. Ltd. (China). Pertussis toxin (PT), mycobacterium tuberculosis and Complete Freund's adjuvant (CFA) were purchased from Sigma-Aldrich (USA). Cytokine ELISA kits were purchased from Boster Life Technologies (China). For real-time RT-PCR, all primers were purchased from Takara Life Technologies (Japan).
Mice. C57BL/6 (8-10 weeks old) female mice were purchased from Shanghai SLAC Laboratories animal Co. Ltd and were housed under a 12-h light/dark cycle in microisolater cages contained within a laminar flow system to maintain a pathogenfree environment. Experiments were conducted in accordance with the Animal Component of Research Protocol guidelines at the China Medical University.
Animal model of EAE. C57BL/6 mice were immunized by subcutaneous (s.c.) injection at two sites on the back with 200 μg MOG peptide dissolved in distilled water and emulsified with an equal volume of CFA supplemented with 4 mg/ml mycobacterium tuberculosis H37Ra. Intra-peritoneal injections were also given to all animals on days 0 and 2 with 400 ng PT. Control animals followed an identical immunization protocol (adjuvant + pertussis) without added MOG. Animals were weighed daily and assessed for clinical signs of EAE by two independent observers. We used the same clinical EAE scoring system to assess neurological deficit in our mouse EAE model according to the following scale: 0, no disease; 1, loss of weight and tail weakness; 2, weakness in hind limbs; 3, complete hind limb paralysis; 4, hind limb paralysis with fore limb weakness or paralysis; and 5, moribund or deceased.
Pathologic examination. Mice were anesthetized, exsanguinated, and perfused with 25 ml PBS and 10 ml 4% paraformaldehyde in buffered PBS. Optic nerves were dissected 11, 15 and 19 days after immunization with MOG and fixed in 4% paraformaldehyde before embedding in paraffin. For histological study of ON, whole eyes were collected, and immersed for 1 h in 4% phosphate-buffered glutaraldehyde, and then transferred to 10% phosphate-buffered formaldehyde until processed. Fixed and dehydrated tissue was embedded in methacrylate and 5 μm sections were cut through the pupillaryoptic nerve plane and stained with hematoxylin and eosin. Evaluation of presence or absence of disease was masked by examining six sections cut at different levels for each eye.
Tissues for electron microscopy (EM)
. EM study were fixed in 2.5% gluteraldehyde in phosphate buffer pH 7.4, post osmicated and processed routinely for EM examination. Transverse ultrathin sections of whole optic nerves were examined using H-600 transmission electron microscope.
ELISA for measurement of IFN-Á, IL-17 and IL-4.
Concentration of cytokines was estimated by a sandwich immuno-assay procedure, using a combination of monoclonal and polyclonal antibodies, as described in the manufacturer's protocol (Boster).
Purification of mRNA and real-time RT-PCR. Total RNA was extracted from tissues using an RNA isolation kit (Takara). Complementary DNA was prepared as recommended and used as the template for quantitative PCR. Levels of mRNA for IL-4, IL-17, IFN-Á, and Foxp3 from optic nerves from all groups of mice were analyzed by RT-PCR. RT-PCR was performed according to the manufacturer's instructions. Primers were designed on different exons using primer express software and each PCR product was confirmed as a single band by agarose gel electrophoresis analysis. Then, 2 μl cDNA from the superscript II reaction described above was mixed with 1 X SYBR Green PCR Master mix, specific primer pairs, and deionized water in a total volume of 20 μl. PCR cycling conditions were 8 min at 95˚C followed by 45 cycles of 95˚C for 5 sec, 60˚C for 34 sec and 72˚C for 15 sec. The mRNA level for each sample was normalized against GAPDH mRNA. Specific primers are shown in Table I .
Statistical analysis. Data are expressed as the mean ±SD. Student's two-tailed t-test was used to analyze the results.
P-values ≤0.05 were considered significant.
Results
Histopathology in optic nerve of EAE mouse. MOG-treated mice developed severe clinical manifestations, starting on days 12-14, increasing in severity and resulting in death by day 19. All animals were affected and mild or complete hind limb paralysis was observed in most animals. Fig. 1 shows the development of clinical signs of EAE in mice. To evaluate the inflammation and ultra structure of the optic nerve with the development of disease, optic nerves were examined by histological methods using light microscopy and eletron microscopy at 11, 15 and 19 days following MOG injection. H&E staining (Fig. 2 ) and ultra structure observation (Fig. 3) revealed marked multifocal and lymphohistiocytic inflammation in white matter, which was both perivascular and diffused, and myelin loss in MOG-treated mice, especially around inflamed areas. Representative slides exemplifying optic nerve lesions are presented in Figs. 2 and 3. 
Discussion
ON is an acute inflammatory demyelinating condition of the optic nerve often observed in 2 general settings, idiopathic and MS. In ~20% of MS patients, ON is the presenting manifestation of the disease (clinically isolated demyelinating syndrome, CIS) (18) . Furthermore, ON can occur at any point of time in the lifetime of a patient with MS approaching a frequency of 66% (19) . Ninety percent of clinically definite MS (CDMS) patients have electrophysiological evidence of ON based on visual-evoked potentials (20) . Based on several older retrospective studies, the conversion rate of ON to MS has varied widely ranging from 8 to 85% (21) . The potential for conversion to MS highlights the importance of investigating ON. EAE serves as an animal model that recapitulates many features of MS. It can be induced by immunization of susceptible animals with a number of myelin antigens including myelin basic protein (MBP) (22) , proteolipid protein (PLP) (23) (24) (25) , and myelin oligodendrocyte glycoprotein (MOG) (26) . MOG, although a minor component, ~0.05%, of the myelin sheath, has been shown to be a potent encephalitogenic protein that induces EAE in many strains and species of experimental animals (27) (28) (29) (30) (31) , and is also implicated in the pathogenesis of MS (32, 33) . In EAE, the identity of the target auto antigen, at least in part, determines the disease phenotype and pattern of lesion distribution in the CNS. For example, immune responses to MBP or PLP induce lesions located predominantly in the spinal cord whereas immunization with MOG generates mainly optic nerve and spinal cord lesions (34) . Optic nerve lesions have been reported in some forms of EAE, but have always been associated with the presence of inflammation and demyelination of the brain and spinal cord (9, 12, (35) (36) (37) . In the present study we take advantage of EAE, model of lesions located predominantly in the optic nerve, to observe the role of the main four T helper cell subsets Th1, Th2, Th17 and Treg during different stages of disease. MS is an autoimmune disease of the CNS that perhaps is mediated in part by T cells (16) . Historically, Th1 and Th2 cells have been characterized as two classic CD4 + T cell subsets that secrete pro-inflammatory cytokines, such as IFN-Á, or anti-inflammatory cytokines, such as IL-4, IL-5, IL-10 and IL-13, respectively. Recent studies have identified two new CD4 + T cell subsets in addition to the well-known Th1-and Th2-like cells. One is the naturally thymus-born Foxp3 + T regulatory (Foxp3 + Treg) cell (36) (37) (38) , which functions as an inhibitor of the initiation and/or development of certain immune cell responses, and are considered to be antiinflammatory in nature. The other is the T helper 17 (Th17) cell that secretes IL-17 and promotes inflammation and autoimmunity (39, 40) . Because an inflammatory response in the CNS can cause neuronal damage and may be involved in the pathogenesis of several neurodegenerative diseases (41) , it appears to be the Th1 and Th17 cells associated with EAE, which is characterized by neuronal degeneration and myelin degradation (42) . In contrast, a shift in the immune response toward the activation of Th2 or Treg cells has been reported to delay neurodegenerative disease onset and/or inhibit disease progression (43) (44) (45) (46) . Therefore, in this study, we identified the phenotype of CD4 + T cells that develop in optic neuritis in the EAE mouse model. The present result supports that all known CD4 + T cell subsets develop after optic nerve injury. The data show that (i) pro-inflammatory Th1 and Th17 cells increase after optic neuritis, and with a different cytokine expression peak by 11 and 19 days respectively; (ii) Anti-inflammatory Th2 and Treg cells show a decline in the optic nerve of EAE mice. The former decrease at 19 days after immunization, and the latter has an obvious down-regulation from 11 to 19 days after immunization. Here, we not only investigated the two classic CD4 + T subsets, i.e., pro-inflammatory Th1 cells and anti-inflammatory Th2 cells, previously implicated in neural injury and repair, but also examined the development of the recently identified Th17, and Treg cells (11, 47) . The data indicate that balance of CD4 + T subsets is crucial to keep immune homeostasis. Some diseases will occur once the balance is broken. While CD4 + T cell subsets mutually inhibit development of each other, recent evidence suggests that naive T cells (in mice) are induced to differentiate along a pathway favoring development of Th17 or Treg cells in a mutually exclusive manner (11, 48, 49) . Indeed, the Th17 population is important in mediating autoimmune diseases in animals (50, 51) . As a result, a novel hypothesis has been proposed (39) with regards to inflammatory and autoimmune diseases, namely that skewing responses towards Th17 or Th1 and away from Treg (and Th2) may be responsible for the development and progression of autoimmune disease (AD) and that a blockade of critical cytokines may result in a shift in this polarization from Th17/Th1 phenotypes towards Treg and Th2 (i.e. that regulation and deregulation are inducible and remediable).
Our observations suggest that during the early stage of EAE, there is a imbalance of Th17/Treg cells in the optic nerve, but the imbalance of Th1/Th2 seen in the optic nerve occurs at a later stage of EAE. Treg cells show a significant role in the development of optic neuritis in EAE by down-regulating the gene expression from an earlier to a later stage, so its inhibit function to all CD4 + T subsets, especially to Th1 and Th17 cells, declined obviously. Then we observed high expression of Th1 and Th17 cytokines. Th1 and Th17 cells are known as proinflammatory subsets. One of the major Th1 cell-derived cytokines is IFN-Á. IFN-Á is a potent pro-inflammatory cytokine. The major cytokine secreted by Th17 cells is IL-17, which is involved in tissue inflammation and autoimmunity (51, 52) . Expression of high levels of pro-inflammatory cytokines and chemokines in the CNS are thought to contribute to the initiation and maintenance of EAE (53, 54) . By contrast, anti-inflammatory Th2 cells were given a mild inhibition by Treg cell subsets and show a moderate decrease accordingly in the optic nerve of EAE.
We studied the role of four T helper cell subsets in the development of optic neuritis in EAE. We concluded that all CD4 + T cell subsets participate in the development of optic neuritis in EAE and imbalance of CD4 + T cell subsets may contribute to the pathogenesis of optic neuritis. We also observed an early increase of Th17 cell subsets and later increase of Th1 cell subsets, possibly a result from the decrease of Treg cell subsets in optic nerve of EAE. The detection of IL-17, IFN-Á and Foxp3 gene expression in different stages of the disease will become an important diagnostic index. Cytokines will play a critical role in therapy and prevention of optic neuritis clinically by immune therapy, maintaining the balance of Thl7, Treg, Thl, Th2 cell subsets and inhibiting inflammation.
